Landoll, founded in 1966 and based in Milan and Ricengo (Cremona), designs, manufactures, and distributes premium shampoos, conditioners, and other hair and skin-care products under the Nashi and Nashi Argan brands. It distributes through ~7,000 hairdressers and 18 monobrand stores in Italy and 40 other countries across Europe, Asia, and Latin America. In 2021 the group posted revenues of ~26 million euros – up 28% vs. 2020 – and EBITDA of around 6 million euros. In the last 10 years, the company has grown on average by 18% per year, thanks to the quality of its products, an active presence on social media, and the careful selection of its hairdresser partners.
Founded in 1946 and led since then by the Baracchi family, Baraclit is the leading manufacturer of concrete prefabricated buildings for the industrial and commercial segments in Italy, with a 300.000 square meter plant in Bibbiena – in the Italian province of Florence -, 350 employees and a turnover of over € 70 million. Throughout its history, Baraclit has manufactured more than 15,000 buildings covering more than 22 million square meters. Its semi-transparent “Aliant” roofs stepped up the industry standards for brightness of industrial and commercial buildings. Its b.POWER division is a center of excellence specialized in rooftop solar panels.
Spactiv Spa. Is a Special Purpose Acquisition Company (“SPAC”). Founded by Milano Capital and the Borletti Group in July 2017, it raised € 90 million from Italian and international investors in a widely oversubscribed Initial Public Offering in September 2017. On September 12th 2019, Spactiv announced a deal for a merger – eventually suspended due to the consequences of the COVID outbreak – with Betty Blue, a fashion house owned by the well-known stylist and entrepreneur Elisabetta Franchi.
Dianax designs and manufactures portable testing devices to analyze blood and other body fluids. Its patented, low-cost, award-winning technology allows for high precision, robustness, durability, portability, and ease of use. Founded in 2013, as of today Dianax raised € 4 million from Private and Institutional Investors. In 2015 it won the “Seal of Excellence” award from the European Community and in 2016 it was selected for the Horizon 2020 programme, resulting in a € 2 million grant. In 2020 it raised fresh capital to fund a new business line focused on distributing portable COVID tests. Dianax’ goal is to prevent and help treat diseases affecting more than 1 billion people and including diabetes and anaemia.